What Wiltrom does

Wiltrom Co., Ltd. (台灣微創醫療器材股份有限公司) is a Taiwan-based medical device company that designs, manufactures, and commercializes implantable spinal surgery devices. Founded in December 2009 as a spin-off from the Industrial Technology Research Institute (ITRI), the company is publicly listed on the Taiwan Stock Exchange (ticker 6767) and headquartered in Zhubei City within the Hsinchu biomedical corridor. The company serves acute care hospitals and specialized spine surgery centers globally through four core product lines: a Vertebral Body Augmentation System anchored by its flagship TRIPOD-FIX® implant, Vertebroplasty Bone Cement, Bone Graft Substitute, an Interbody Fusion System, and a Spinal Fixation System, complemented by proprietary surgical instruments. The technology stack integrates material science, mechanical engineering, and advanced manufacturing in a single ISO 13485-certified, fully integrated production system that supports both volume scale-up and high-precision manufacturing with multi-stage quality inspection.

Wiltrom holds more than 50 patents spanning its four product lines and dedicates approximately 30% of its workforce to R&D. It has secured regulatory clearances across the major medical device jurisdictions it targets: Taiwan (TFDA), United States (FDA), European Union (CE), China (NMPA), and Colombia (INVIMA), with additional approvals described as in progress. The TRIPOD-FIX® implant has been the subject of multi-center clinical trials in Germany to support European market development.

The company operates a B2B medical device sales model, generating revenue through direct hospital sales of proprietary spinal hardware using quotation-based pricing. Its go-to-market combines clinical evidence generation with international market development via participation in spine-focused conferences and clinical training events such as EUROSPINE 2025, the 2025 Thailand Medical Expo, and surgeon symposia in Vietnam, Colombia, Brazil, and Germany. Reported cumulative annual revenue reached approximately TWD 311,774 thousand (~USD 9.7M at recent FX) in 2025, with the historical trajectory running from TWD 75,261 thousand in 2019 to TWD 282,538 thousand in 2023, implying a sharp deceleration from the prior 36–43% year-over-year growth pace into single-digit growth in 2024–2025.

Name

Wiltrom

Legal name

台灣微創醫療器材股份有限公司

Website

https://wiltrom.com.tw

Company type

Public

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Wiltrom is a Taiwan-based medical device company that develops and commercializes implantable spinal surgery devices across four product lines, selling directly to hospitals and spine surgery centers globally, with regulatory approvals in the US, EU, China, Taiwan, and Colombia.

Ownership category

akta.pro rank

Product category

Spinal Surgery Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industry

Spine (Orthopedic Spine) (HLAKALAE)

Keywords

• Spinal surgery devices
• Vertebral augmentation systems
• Orthopedic bone cements
• Bone graft substitutes
• Spinal fixation implants

Headquarters

HQ city

Hsinchu

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Spinal Implant and Medical Device Sales: Wiltrom generates revenue through the sale of proprietary spinal surgery medical devices and instruments, including vertebral augmentation systems, interbody fusion cages, spinal fixation hardware, bone graft substitutes, and bone cement. Products are sold to hospitals and spine surgery centers following regulatory approvals in each market.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Wiltrom develops, manufactures, and sells spinal surgery medical devices and instruments, including the TRIPOD-FIX® Vertebral Body Augmentation System, vertebroplasty bone cement, bone graft substitutes, interbody fusion systems, spinal fixation systems, and supporting surgical instruments. The company supplies hospitals and spine surgeons with comprehensive procedural solutions across four product lines backed by 50+ patents. Founded in 2009 as an ITRI spin-off, the company operates from Zhubei City, Hsinchu County, Taiwan.

Product overview

Wiltrom Co., Ltd. (台灣微創醫療器材股份有限公司) is a Taiwan-based medical device company founded in 2009 as a spin-off from the Industrial Technology Research Institute (ITRI). The company develops, manufactures, and commercializes a portfolio of high-end implantable spinal surgery devices, organized across four major product lines. The product portfolio includes the Vertebral Body Augmentation System (featuring the TRIPOD-FIX® sub-brand implant), Verterbroplasty Bone Cement, Bone Graft Substitute, Interbody Fusion System, Spinal Fixation System, and supporting surgical Instruments. The company dedicates approximately 30% of its team to R&D and holds over 50 patents across its product lines. Products are manufactured in ISO 13485-certified facilities and have received regulatory approvals in the USA (FDA), EU (CE), China (NMPA), Taiwan (TFDA), and Colombia (INVIMA), with active market sales.

Differentiator

Problem solved

Functional benefit

Brands

• TRIPOD-FIX: Vertebral Body Augmentation System - a key spinal surgery product for vertebral body augmentation procedures
• Interbody Fusion System
• Spinal Fixation System
• Bone Graft Substitute
• Vertebroplasty Bone Cement

Products and services

• TRIPOD-FIX® Vertebral Body Augmentation System

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Industrial Technology Research Institute (ITRI)coreStrategic or Co-development PartnerWiltrom was founded as an ITRI spin-off venture in December 2009, leveraging ITRI's institutional research capabilities in medical device development. The company's founding as an ITRI new venture provided the initial technological foundation and R&D infrastructure for spinal device innovation.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medtronic (Spine & Biologics): Largest competitor in the global spinal implant market through its Spine & Biologics division. Competes across vertebral augmentation, interbody fusion, and spinal fixation.
• DePuy Synthes (Johnson & Johnson): Spine franchise within Johnson & Johnson's medtech portfolio. Broad incumbent with overlapping cervical, thoracolumbar, and vertebral compression fracture treatment offerings.
• Stryker (Spine division): Diversified medical device major with a spine division offering cervical and thoracolumbar products overlapping with Wiltrom's interbody fusion and fixation lines.

Direct peers

• Alphatec Holdings: US-based spine-focused medical device company with a portfolio similar to Wiltrom's across fixation, interbody fusion, and biologics. Comparable mid-size competitor targeting similar surgeon and hospital customers.
• Orthofix Medical: Spine and orthopedic implant company with overlapping product categories including spinal fixation, bone graft substitutes, and biologics. Comparable as a mid-cap spine specialist.
• Globus Medical: Pure-play spinal implant company with broad portfolio across fusion, fixation, and motion-preservation. Most direct comparable to Wiltrom's spine-focused product strategy and target customer (spine surgeons and hospitals).
• NuVasive (now part of Globus Medical): Spine specialist focused on minimally invasive surgical techniques and interbody fusion. Closely comparable to Wiltrom's MIS positioning and vertebral/interbody fusion product lines.
• SeaSpine (acquired by Globus Medical): Spine-focused medical device company offering spinal hardware and orthobiologics, directly overlapping with Wiltrom's fusion, fixation, and bone graft substitute lines.

Regional players

• AK Medical Holdings: China-based orthopedic implant manufacturer with expanding spine and trauma product lines. Comparable emerging competitor primarily serving Asia-Pacific markets.

Emerging players

• MicroPort Orthopedics (MicroPort Scientific): Asia-based orthopedic and spine implant competitor expanding globally with comparable spinal fixation and fusion offerings. Notable regional peer with growing international presence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/p/%E5%8F%B0%E7%81%A3%E5%BE%AE%E5%89%B5%E9%86%AB%E7%99%82%E5%99%A8%E6%9D%90-Wiltrom-100054625472212
• LinkedIntw.linkedin.com/company/wiltrom
• Instagraminstagram.com/wiltrom_tw

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wiltrom